Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 12 January 2021, 09:56 HKT/SGT
Share:
    

Source: NEC Corporation
NEC Releases 'WISE VISION Endoscopy' in Europe and Japan
- Contributing to early detection of colorectal cancer -

TOKYO, Jan 12, 2021 - (JCN Newswire) - NEC Corporation (TSE: 6701) has announced the development of "WISE VISION Endoscopy," an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan today and is expected to soon be available in Europe. This software connects with existing endoscopy equipment as part of using AI to automatically mark potential lesions from images taken during endoscopic procedures.


Colorectal cancer is the most common cancer in Japan(1), and the second most common in Europe(2). Colorectal cancer originates from precancerous lesions (colorectal neoplastic polyps) and it is possible to suppress the progression to cancer by detecting and removing lesions at the polyp stage during endoscopy procedures. However, polyps need to be found with the eye of an endoscopist, and are often difficult to detect because of their size and shape, causing approximately 24%(3) to be missed, thereby delaying detection.

NEC has been working with the National Cancer Center Japan since 2016 to contribute to resolving this issue. NEC has now developed software that can automatically mark potential lesions based on the use of AI to learn from endoscopic images of more than 10,000 lesions, as well as learning from the observations of expert physicians(4). This software was developed by applying NEC's AI technologies, "NEC the WISE," and its face recognition technology, which is highly evaluated by the National Institute of Standards and Technology(5) in the United States.

Software features include the following:

1. Compatibility with the endoscopy systems of three leading companies and usability in any examination room
This software can be connected to endoscopes from three leading endoscope manufacturers(6). By simply connecting an existing endoscope to a monitor and terminal equipped with the software, users can start using it immediately. Moreover, since it is compatible with various endoscopes and easy to prepare, systems can be transferred within different rooms and used efficiently wherever there is an examination.

2. High visibility and flexible interface
The system marks the lesion candidates with a notification sound and marking. Notification sounds, volume, and marker colors can be customized at any time to the user's preference. The system can be operated intuitively with a high-visibility user interface, allowing users to smoothly proceed with examinations.

Going forward, as a company that creates social value, NEC aims to promote a healthy, and sustainable society, where individuals can thrive from the utilization of advanced IT technologies.

(1) According to statistics from the National Cancer Research Center Japan (Japanese text only) https://ganjoho.jp/reg_stat/statistics/stat/summary.html
(2) According to United European Gastroenterology https://ueg.eu/p/78#
(3) Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112(1):24-28
(4) Yamada M, Saito Y, Imaoka H,et al. Development of a real-time endoscopic image diagnosis support system using deep learning technology in colonoscopy. Sci Rep. 2019;9:14465
(5) NEC Face Recognition Technology Ranks First in NIST Accuracy Testing
https://www.nec.com/en/press/201910/global_20191003_01.html
(6) Connectivity and operations have been confirmed with the following endoscopes
- Olympus EVIS LUCERA ELITE Video System Center CV-290
- FUJIFILM ELUXEO video processor VP-7000
- PENTAX Medical OPTIVISTA EPK-i7010 video processor

Product name: WISE VISION Endoscopy

About NEC Corporation

NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com.


Topic: Press release summary
Source: NEC Corporation

Sectors: MedTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


NEC Corporation Links

http://www.nec.com

https://www.facebook.com/nec.global/

https://twitter.com/NEC_corp

https://www.youtube.com/user/NECglobalOfficial

https://www.linkedin.com/company/nec/

NEC Corporation
Nov 28, 2025 18:41 HKT/SGT
JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information
Nov 27, 2025 21:31 HKT/SGT
NEC Launches Sales Support Solution Utilizing Agentic AI
Nov 19, 2025 22:15 HKT/SGT
NEC Presents the Decarbonization Potential of its CropScope Agricultural Solution at COP30
Nov 17, 2025 20:38 HKT/SGT
NEC Advances Research Information Infrastructure for Open Science
Nov 13, 2025 23:41 HKT/SGT
The University of Osaka D3 Center and NEC Demonstrate Wide-Area Distributed Campus AI Processing Platform
Nov 10, 2025 17:01 HKT/SGT
JFCR and NEC Confirm Research Results for Developing Individualized Neoantigen Cancer Vaccines Using Whole-Genome Data
Nov 10, 2025 16:32 HKT/SGT
NEC Wheelchair Singles Masters 2025 to begin
Nov 10, 2025 16:00 HKT/SGT
Indicio Secures Investment from NEC X, Accelerating A New Era of User-Controlled Digital Identity
Nov 6, 2025 16:30 HKT/SGT
Stripe and NEC to Provide Face Recognition Payment Service via Stripe Terminal
Nov 4, 2025 23:57 HKT/SGT
NEC and Siemens collaborate to accelerate smart factory innovation
More news >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: